BioWorld MedTech

Nov. 17, 2014

Medica 2014: Molecular diagnostics continue moving from lab to the stomach

DÜSSELDORF, Germany — Moving a microscope from the pathologist's bench into an endoscope broke new ground and carved out a niche in the assessment of gastroenterological and pulmonary diseases for Mauna Kea Technologies (MKT; Paris). Read More

Personal Genome Diagnostics launches targeted gene panel

Lightsaber-like scalpel cuts and coagulates simultaneously

Inside the Beltway: Pivotal trial for Alcon's Acrys of hits efficacy; FDA wary of lost data

Asia in the Spotlight: Trade agreements open prospects for MNC device companies in China

MDD's Stock Watch

Financings: AxoGen reduces debt through a financial agreement with Oberland

Court Report: Boston Sci ordered to pay $26.7M for faulty transvaginal mesh devices

Agreements/contracts: Beckman Coulter Diagnostics gets assay supply accord with Seegene

World in Review: ViewRay receives CE mark for MRIdian guided therapy system

Daily M&A: Catalent reveals its plan to acquire Micron Technologies

MiD study shows data on Medtronic ICM and ESRD

Product briefs

People in Places

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...